Comparing two treatments for blood flow in living donor liver transplants
Treatments studied
Part of Digestive system clinical trials.
This study compares two ways to manage blood flow in the new liver after a living-donor transplant: a medication (octreotide) versus a surgery on the spleen artery. The goal is to improve liver function and reduce complications for patients receiving a smaller-than-usual liver graft.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 69 years old.
- You are scheduled to receive a liver transplant from a living donor.
- Your doctor says you need special management for the new liver because the donated part may be small for your body (called a small-for-size graft).
- You are not pregnant.
- You do not have a known allergy to octreotide or similar medicines.
- You agree to participate and give your informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial explores using smaller liver grafts in a partial transplant to treat portal hypertension, which may help patients avoid full transplant risks. It compares this approach to standard liver transplant.
This study looks at how well CT scans and MRI scans (MRCP) show the blood vessels in the liver before a living donor liver donation. It aims to find out which scan is better at planning the surgery.
This trial tests a new way to control blood flow during laparoscopic liver surgery. It compares two methods to see which is safer and more effective for patients with certain liver conditions.
This study looks at how the donor's liver grows back after donating a part of it for a living donor liver transplant. If you have donated a part of your liver between 2004 and 2026, joining could help doctors learn more about liver healing.
This study looks at living donor liver transplant care and follows patients for about 3 years to see how they do over time. If you had (or are scheduled for) a living donor liver transplant and can be followed long-term, this trial may be able to collect your outcomes.
This trial tests if giving less fluid during liver transplant surgery helps recovery. It is for adults with end-stage liver disease receiving a transplant.
Hear when a new Small-for-Size Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.